Skip to main content
Clinical Trials/NCT04824495
NCT04824495
Unknown
Not Applicable

Evaluation of Inflammatory Cytokines During COVID-19

University of Vienna1 site in 1 country100 target enrollmentJanuary 7, 2021
ConditionsCovid19

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Covid19
Sponsor
University of Vienna
Enrollment
100
Locations
1
Primary Endpoint
Cytokine level in context with clinical parameters
Last Updated
5 years ago

Overview

Brief Summary

The aim of this study is to evaluate pro-inflammatory cytokines as well as microvesicles during the course of SARS-CoV2 infection in the context of clinical parameters.

Detailed Description

In this prospective trial, 100 patients with an acute SARS-CoV2 infection are enrolled. After confirmation of COVID-19, blood samples are taken for evaluation of various inflammatory cyokines and microvesicles at day 1, 5, 9 and 13 during hospitalisation and are interpreted in the context of clinical parameters.

Registry
clinicaltrials.gov
Start Date
January 7, 2021
End Date
December 31, 2021
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Daniela Gompelmann

Prof. Dr. med.

University of Vienna

Eligibility Criteria

Inclusion Criteria

  • Age \> 18 years
  • Confirmation of acute SARS-CoV2 infection
  • Ability to provide informed consent

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Cytokine level in context with clinical parameters

Time Frame: 2 weeks

Study Sites (1)

Loading locations...

Similar Trials